Press Releases

On September 21-24, the 37th Congress of the European College of Neuropsychopharmacology (ECNP) was held in Milan, Italy. The latest clinical research...

The European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain, from September 13 to 17 (local time). Hansoh Pharma's inn...

Recently, Healthcare Executivereleased the 2024 Top 100 China Pharmaceutical Innovation Companies, where Hansoh Pharma maintains its position in the f...

The 60th Annual Meeting of the European Association for the Study of Diabetes (EASD) was held in Madrid, Spain, from 9 to 13 September 2024. Hansoh Ph...

On August 19, 2024, Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma," 03692.HK) announced that the new drug application ("NDA") for a new indica...

A real-world study of GLP-1 receptor agonists (GLP-1RAs) for treating patients with diabetic kidney disease (DKD) was recently published in the intern...

On July 19, 2024, Hansoh Pharma's New Drug Application (NDA) for Ameile (almonertinib mesylate tablets), an independently-developed class 1 new drug, ...

The 2024 ADA Meeting was held in Orlando, USA, from June 21st to 24th, this year. Hansoh Pharma's HS-20094 (a novel Dual GIP and GLP-1 Receptor Agonis...